[HTML][HTML] A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
The spike glycoprotein of SARS-CoV-2 engages with human ACE 2 to facilitate infection.
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
[HTML][HTML] A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - 2022 - europepmc.org
The spike glycoprotein of SARS-CoV-2 engages with human angiotensin-converting
enzyme 2 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain …
enzyme 2 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain …
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - …, 2022 - pubmed.ncbi.nlm.nih.gov
The spike glycoprotein of SARS-CoV-2 engages with human ACE 2 to facilitate infection.
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - 2022 - pesquisa.bvsalud.org
The spike glycoprotein of SARS-CoV-2 engages with human angiotensin-converting
enzyme 2 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain …
enzyme 2 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain …
[HTML][HTML] A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - iScience, 2022 - ncbi.nlm.nih.gov
The spike glycoprotein of SARS-CoV-2 engages with human ACE 2 to facilitate infection.
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - bioRxiv, 2022 - biorxiv.org
The spike glycoprotein of SARS-CoV-2 engages with human angiotensin-converting
enzyme 2 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain …
enzyme 2 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain …
[引用][C] A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - …, 2022 - ui.adsabs.harvard.edu
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants - NASA/ADS Now
on home page ads icon ads Enable full ADS view NASA/ADS A potent alpaca-derived …
on home page ads icon ads Enable full ADS view NASA/ADS A potent alpaca-derived …
[HTML][HTML] A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - iScience, 2022 - Elsevier
The spike glycoprotein of SARS-CoV-2 engages with human ACE 2 to facilitate infection.
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - …, 2022 - ohsu.elsevierpure.com
The spike glycoprotein of SARS-CoV-2 engages with human ACE 2 to facilitate infection.
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that …
[PDF][PDF] A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
JB Weinstein, TA Bates, HC Leier, SK McBride… - scholar.archive.org
The spike glycoprotein of SARS-CoV-2 engages with human angiotensin-converting
enzyme 2 12 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain …
enzyme 2 12 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain …